Global Information
회사소개 | 문의 | 비교리스트

세계의 다클론항체 시장(2020-2027년) : 시장 예측(종류, 용도, 지역별), 시장 점유율, 시장 기회 분석

Polyclonal Antibody Market, by Type, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

리서치사 Coherent Market Insights
발행일 2020년 12월 상품 코드 980031
페이지 정보 영문
가격
US $ 4,500 ₩ 5,470,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,509,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 12,156,000 PPT Turned PDF (Enterprise User License)


세계의 다클론항체 시장(2020-2027년) : 시장 예측(종류, 용도, 지역별), 시장 점유율, 시장 기회 분석 Polyclonal Antibody Market, by Type, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
발행일 : 2020년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 다클론항체 시장 성장은 암 발병률 상승, 지속적인 다클론항체 개발 등의 요인에 의해 가속할 것으로 예측됩니다.

세계의 다클론항체(Polyclonal Antibody) 시장을 조사했으며, 시장의 정의와 개요, 코로나19(COVID-19) 및 기타 시장 영향요인 분석, 법규제 환경, 파이프라인 동향, 시장 규모 추이와 예측, 종류·용도·지역 등 각종 구분별 분석, 경쟁 환경, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

제1장 조사 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 법규제, 동향 분석

  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
  • 영향 분석
  • 파이프라인 분석
  • PEST 분석
  • 규제 시나리오
  • 신제품 발매
  • 제휴/계약
  • 시장 동향

제4장 COVID-19의 영향

제5장 시장 분석과 예측 : 유형별

  • 1차 항체
  • 2차 항체

제6장 시장 분석과 예측 : 용도별

  • 학술연구
  • 상용

제7장 시장 분석과 예측 : 지역별

  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제8장 경쟁 구도

  • 히트맵 분석
  • 시장 점유율 분석
    • Abcam plc
    • GenScript
    • Merck KGaA.
    • IgY Immune Technologies & Life Sciences Inc.
    • Thermo Fisher Scientific Inc.
    • Takara Bio Inc.
    • Genway Biotech, Inc.
    • Geno Technology Inc.
    • DC Biosciences Ltd.
    • Good Biotech Corp
    • Rockland Immunochemicals, Inc.
    • EpiGentek Group Inc.
    • Innovagen AB.
    • GeneTex, Inc.

제9장 애널리스트의 견해

제10장 섹션

LSH 21.01.14

Title:
Polyclonal Antibody Market, by Type (Primary Antibody and Secondary Antibody), by Application (Academic Research and Commercial), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Antibodies are the type of globular proteins produced by the plasma cells. Polyclonal antibodies are produced by different types of plasma B cells and bind to different epitopes in the same antigen. Polyclonal antibodies are heterogeneous mixture of antibodies and are inexpensive to produce. Polyclonal antibodies are used in therapeutics as well as in research applications.

Market Dynamics

Rising incidence of cancer is expected to drive the global polyclonal antibody market growth. For instance, according to an article published by the Cancer Research UK, 367,167 new cases of cancer were reported between 2015 and 2017 in the U.K.

Moreover, ongoing development of polyclonal antibodies is expected to drive the market growth. For instance, in March 2020, GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, announced that the company is developing a recombinant polyclonal antibody therapy for the treatment of COVID-19. The recombinant anti-coronavirus 19 hyperimmune gammaglobulin (rCIG) is in development to treat high-risk and severely ill individuals infected with COVID-19.

Key features of the study:

  • This report provides in-depth analysis of the global polyclonal antibody market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global polyclonal antibody market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Abcam plc, GenScript, Merck KGaA., IgY Immune Technologies & Life Sciences Inc., Thermo Fisher Scientific Inc., Takara Bio Inc., Genway Biotech, Inc., Geno Technology Inc., DC Biosciences Ltd., Good Biotech Corp, Rockland Immunochemicals, Inc., EpiGentek Group Inc., Innovagen AB. and GeneTex, Inc. among others.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global polyclonal antibody market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global polyclonal antibody market.

Detailed Segmentation:

  • Global Polyclonal Antibody Market, By Type:
    • Primary Antibody
    • Secondary Antibody
  • Global Polyclonal Antibody Market, By Application:
    • Academic Research
    • Commercial
  • Global Polyclonal Antibody Market, By Region:
    • North America
      • By Type:
      • Primary Antibody
      • Secondary Antibody
      • By Application:
      • Academic Research
      • Commercial
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Type:
      • Primary Antibody
      • Secondary Antibody
      • By Application:
      • Academic Research
      • Commercial
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Type:
      • Primary Antibody
      • Secondary Antibody
      • By Application:
      • Academic Research
      • Commercial
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Type:
      • Primary Antibody
      • Secondary Antibody
      • By Application:
      • Academic Research
      • Commercial
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Type:
      • Primary Antibody
      • Secondary Antibody
      • By Application:
      • Academic Research
      • Commercial
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Type:
      • Primary Antibody
      • Secondary Antibody
      • By Application:
      • Academic Research
      • Commercial
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Abcam plc*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • GenScript
    • Merck KGaA.
    • IgY Immune Technologies & Life Sciences Inc.
    • Thermo Fisher Scientific Inc.
    • Takara Bio Inc.
    • Genway Biotech, Inc.
    • Geno Technology Inc.
    • DC Biosciences Ltd.
    • Good Biotech Corp
    • Rockland Immunochemicals, Inc.
    • EpiGentek Group Inc.
    • Innovagen AB
    • GeneTex, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Polyclonal Antibody Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Market Scenario
  • Impact of COVID-19 Market on the Polyclonal Antibody Products

5. Global Polyclonal Antibody Market, By Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Primary Antibody
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Secondary Antibody
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Polyclonal Antibody Market, By Application, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Academic Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Commercial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Polyclonal Antibody Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Abcam plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GenScript
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck KGaA.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • IgY Immune Technologies & Life Sciences Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Takara Bio Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Genway Biotech, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Geno Technology Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • DC Biosciences Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Good Biotech Corp
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rockland Immunochemicals, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • EpiGentek Group Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Innovagen AB.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GeneTex, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q